Min‐Wu Chao

719 citations

26 papers · 492 indexed · h-index 15

Co-authors: Shiow‐Lin Pan Jing‐Ping Liou Che‐Ming Teng Huang‐Ju Tu Kai‐Cheng Hsu Wei‐Chun HuangFu Tony Eight Lin Mei‐Jung Lai
Topics: Histone Deacetylase Inhibitors Research (7 papers)Cancer Mechanisms and Therapy (6 papers)Computational Drug Discovery Methods (3 papers)
Cited by: Oncology Molecular Biology Toxicology
Journals: Scientific Reports Carcinogenesis Protein Science
Partner nations: Taiwan United States China

In The Last Decade

Min‐Wu Chao

26 papers receiving 488 citations

Peers

Countries citing papers authored by Min‐Wu Chao

Since Specialization

Citations

This map shows the geographic impact of Min‐Wu Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min‐Wu Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min‐Wu Chao more than expected).

Fields of papers citing papers by Min‐Wu Chao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min‐Wu Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min‐Wu Chao. The network helps show where Min‐Wu Chao may publish in the future.

Co-authorship network of co-authors of Min‐Wu Chao

This figure shows the co-authorship network connecting the top 25 collaborators of Min‐Wu Chao. A scholar is included among the top collaborators of Min‐Wu Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min‐Wu Chao. Min‐Wu Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown),Min‐Wu Chao,Hsueh‐Yun Lee,Yiting Liu,Huang‐Ju Tu,(unknown),Tony Eight Lin,Tzu-Ying Sung,(unknown),(unknown),Kai‐Cheng Hsu,Shiow‐Lin Pan	5
2	O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia 2022 ·Phytomedicine ·(unknown),Yiwen Wu,(unknown),Min‐Wu Chao,Huang‐Ju Tu,Liang‐Chieh Chen,Tony Eight Lin,Tzu-Ying Sung,(unknown),(unknown),Wei‐Jan Huang,Chia‐Ron Yang,Wei‐Chun HuangFu,Shiow‐Lin Pan,Kai‐Cheng Hsu	7
3	Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment 2021 ·Biomedicine & Pharmacotherapy ·Tony Eight Lin,Chia‐Ron Yang,(unknown),(unknown),Min‐Wu Chao,Tzu-Ying Sung,Jui‐Hua Hsieh,Wei‐Jan Huang,Kai‐Cheng Hsu	15
4	A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo 2021 ·Oncogenesis ·(unknown),Min‐Wu Chao,Huang‐Ju Tu,Liang‐Chieh Chen,Kai‐Cheng Hsu,Jing‐Ping Liou,Chia‐Ron Yang,(unknown),Wei‐Chun HuangFu,Shiow‐Lin Pan	24
5	Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo 2021 ·European Journal of Medicinal Chemistry ·Yi-Min Liu,Huang‐Ju Tu,(unknown),Mei-Jung Lai,(unknown),Min‐Wu Chao,(unknown),Che‐Ming Teng,Shiow‐Lin Pan,Jing‐Ping Liou	14
6	Identification and analysis of a selective DYRK1A inhibitor 2021 ·Biomedicine & Pharmacotherapy ·Tony Eight Lin,Min‐Wu Chao,Wei‐Chun HuangFu,Huang‐Ju Tu,Zhaoxiang Peng,(unknown),Tzu-Ying Sung,Jui‐Hua Hsieh,Chien‐Chung Lee,Chia‐Ron Yang,Shiow‐Lin Pan,Kai‐Cheng Hsu	11
7	Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo 2020 ·European Journal of Medicinal Chemistry ·Ritu Ojha,Kunal Nepali,Chun‐Han Chen,Kai‐Hsiang Chuang,(unknown),Tony Eight Lin,Kai‐Cheng Hsu,Min‐Wu Chao,Mei-Jung Lai,Mei-Hsiang Lin,Han-Li Huang,(unknown),Shiow‐Lin Pan,Mei-Chuan Chen,Jing‐Ping Liou	35
8	A site-moiety map and virtual screening approach for discovery of novel 5-LOX inhibitors 2020 ·Scientific Reports ·Kai‐Cheng Hsu,Wei‐Chun HuangFu,Tony Eight Lin,Min‐Wu Chao,(unknown),Yi‐Ying Chen,Shiow‐Lin Pan,(unknown),Shey‐Cherng Tzou,Chung‐Ming Sun,Jinn‐Moon Yang	8
9	Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach 2020 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Min‐Wu Chao,Tony Eight Lin,Wei‐Chun HuangFu,(unknown),Huang‐Ju Tu,Liang‐Chieh Chen,(unknown),(unknown),(unknown),Chia‐Ron Yang,(unknown),Kai‐Cheng Hsu	14
10	N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression 2019 ·European Journal of Medicinal Chemistry ·Samir Mehndiratta,Mei-Hsiang Lin,(unknown),Chun‐Han Chen,(unknown),Kai‐Hsiang Chuang,Min‐Wu Chao,Yi‐Ying Chen,Shiow‐Lin Pan,Mei-Chuan Chen,Jing‐Ping Liou	49
11	Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status 2019 ·Clinical Epigenetics ·Min‐Wu Chao,(unknown),Huang‐Ju Tu,(unknown),Mei-Jung Lai,Yi‐Ying Chen,Jing‐Ping Liou,Che‐Ming Teng,(unknown)	28
12	Amide-tethered quinoline-resorcinol conjugates as a new class of HSP90 inhibitors suppressing the growth of prostate cancer cells 2019 ·Bioorganic Chemistry ·Kunal Nepali,Mei-Hsiang Lin,Min‐Wu Chao,(unknown),Kai‐Cheng Hsu,Tony Eight Lin,Mei-Chuan Chen,Mei-Jung Lai,Shiow‐Lin Pan,Jing‐Ping Liou	17
13	The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells 2018 ·Clinical Epigenetics ·Huang‐Ju Tu,(unknown),Min‐Wu Chao,Ting-Yi Sung,(unknown),Yi‐Ying Chen,(unknown),Jing‐Ping Liou,(unknown),Chia‐Ron Yang	25
14	A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions 2018 ·Frontiers in Pharmacology ·Tony Eight Lin,Wei‐Chun HuangFu,Min‐Wu Chao,Tzu-Ying Sung,(unknown),Yi‐Ying Chen,Jui‐Hua Hsieh,Huang‐Ju Tu,(unknown),Shiow‐Lin Pan,Kai‐Cheng Hsu	31
15	Lanatoside C, a cardiac glycoside, acts through protein kinase Cδ to cause apoptosis of human hepatocellular carcinoma cells 2017 ·Scientific Reports ·Min‐Wu Chao,(unknown),Han-Li Huang,Yu-Wei Chang,Wei‐Chun HuangFu,Yu‐Ching Lee,Che‐Ming Teng,Shiow‐Lin Pan	35
16	Anti-leukemia effects of the novel synthetic 1-benzylindole derivative 21-900 in vitro and in vivo 2017 ·Scientific Reports ·Wei‐Chun HuangFu,Min‐Wu Chao,(unknown),(unknown),(unknown),Jing‐Ping Liou,George Hsiao,Yu‐Ching Lee,Chia‐Ron Yang	4
17	Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancer 2016 ·Carcinogenesis ·En‐Chi Hsu,Samuel K. Kulp,Han-Li Huang,Huang‐Ju Tu,Min‐Wu Chao,(unknown),(unknown),Santosh B. Salunke,Nicholas J. Sullivan,(unknown),Jianying Zhang,Che‐Ming Teng,Wen Fu,Duxin Sun,Max S. Wicha,Charles L. Shapiro,Ching-Shih Chen	20
18	MPT0G066, a novel anti-mitotic drug, induces JNK-independent mitotic arrest, JNK-mediated apoptosis and potentiates antineoplastic effect of cisplatin in ovarian cancer 2016 ·Scientific Reports ·Han-Li Huang,Min‐Wu Chao,(unknown),(unknown),Chun‐Han Chen,Mei-Chuan Chen,(unknown),Jing‐Ping Liou,Che‐Ming Teng,Shiow‐Lin Pan	15
19	LTP-1, a novel antimitotic agent and Stat3 inhibitor, inhibits human pancreatic carcinomas in vitro and in vivo 2016 ·Scientific Reports ·Han-Li Huang,Min‐Wu Chao,(unknown),(unknown),Mei-Chuan Chen,(unknown),Jing‐Ping Liou,Che‐Ming Teng,Shiow‐Lin Pan	9
20	The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo 2015 ·Journal of Hematology & Oncology ·Min‐Wu Chao,Mei‐Jung Lai,Jing‐Ping Liou,Ya‐Ling Chang,(unknown),Shiow‐Lin Pan,Che‐Ming Teng	83

About Min‐Wu Chao

Min‐Wu Chao is a scholar working on Pathology and Forensic Medicine, Toxicology and Molecular Biology, having authored 26 papers that have together received 492 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (7 papers), Cancer Mechanisms and Therapy (6 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Oncology (149 citations), Molecular Biology (364 citations) and Toxicology (14 citations). Min‐Wu Chao has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Shiow‐Lin Pan, Jing‐Ping Liou, Che‐Ming Teng, Huang‐Ju Tu, Kai‐Cheng Hsu, Wei‐Chun HuangFu, Tony Eight Lin, Mei‐Jung Lai, Ya‐Ling Chang and Han-Li Huang. Their work appears in journals such as Scientific Reports, Carcinogenesis and Protein Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact